Turtle Creek Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Turtle Creek Wealth Advisors's REGN Position: Q1 2026 in Review
Turtle Creek Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 18% in Q1 2026, buying an estimated $53.6K and bringing the position to 454 shares worth $351K. The position accounts for 0.03% of the portfolio, ranked #294.
Turtle Creek Wealth Advisors first reported a position in REGN in Q4 2023 and has held it in 3 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Turtle Creek Wealth Advisors held 454 shares of Regeneron Pharmaceuticals worth $351K as of Q1 2026.
- Turtle Creek Wealth Advisors bought 70 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $53.6K.
- Regeneron Pharmaceuticals made up 0.03% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #294 holding.
- Turtle Creek Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.